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ABSTRACT
This study evaluated the molecular epidemiology and biodiversity of Mycobacterium tuberculosis isolates
in Zonguldak, Turkey, and investigated the presence and significance of the LAM7-TUR clone by
spoligotyping and mycobacterial interspersed repetitive unit–variable number tandem repeat (MIRU-
VNTR) analysis. In total, 128 isolates were tested by spoligotyping; 25 selected isolates representative of
the LAM7-TUR clone and similar types were also tested by MIRU-VNTR analysis. In total, 47 distinct
patterns were revealed by spoligotyping, represented by 13 clusters containing between two and 28
isolates (94 isolates in total), and 34 unique patterns (a clustering rate of 73%). Using MIRU-VNTR
analysis, the clustering relationships revealed by spoligotyping were confirmed. The most common
spoligotyping profile was SIT53, followed by SIT41 (LAM7-TUR) and SIT50. The SIT284 clone was
another phylogeographically specific clonal complex whose presence in Turkey may be endemic. The
LAM7-TUR genotype was highly prevalent in Zonguldak.
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INTRODUCTION
Turkey represents a link between Europe and
Asia. In Turkey, tuberculosis remains a consider-
able problem, with a case notification rate of
26.2 ⁄ 100 000 inhabitants in 2002 [1]. Molecular
epidemiological studies of Mycobacterium tubercu-
losis complex (MTC) isolates from Turkey are
limited [2–6]. A study analysing the IS6110 fin-
gerprint pattern diversity of MTC isolates from
Turkey [4] revealed that 25% of the isolates
carried fewer than five copies of IS6110, so that
additional tests were required for discrimination
[7]. Spoligotyping and mycobacterial interspersed
repetitive unit–variable number tandem repeat
(MIRU-VNTR) analysis have revealed a new
clone among MTC isolates, designated LAM7-
TUR, and it has been suggested that this clone is
phylogeographically specific to Turkey [6] and
that it belongs to the Latin-American and Medi-
terranean (LAM) superfamily, based on the
shared absence of spacers 21–24. However, the
phylogenetic significance of this clade has not
been studied, and it has not yet been demon-
strated that the Turkish genotype family of MTC
bacilli is a bona fide subclone of the LAM geno-
type superfamily.
Zonguldak is a city in north-west Turkey, on
the Black Sea coast, with a population of 615 599
inhabitants, of whom 250 282 live in the urban
region. The case notification rate of tuberculosis
for Zonguldak in 2001 was 28.6 ⁄ 100 000 [8]. In
total, 502 cases, including 404 new cases,
were officially reported from Zonguldak during
2003–2005. The primary and secondary drug
resistance rates from this region are high [9], but
no molecular characterisation of M. tuberculosis
isolates has been performed previously in Zon-
guldak. The present study aimed to evaluate the
molecular epidemiology and biodiversity of MTC
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isolates in Zonguldak, and to investigate the
presence and significance of the LAM7-TUR clone
by spoligotyping and MIRU-VNTR analysis.
MATERIALS AND METHODS
Population studied
In total, 128 isolates (42, 39 and 47 isolates from 2003, 2004 and
2005, respectively) were subjected to spoligotyping. Of these,
115 were from pulmonary samples. One strain per patient was
included in the study. The isolates were obtained from patients
attending the two tuberculosis dispensaries in the region and
Zonguldak Karaelmas University Hospital, which also serves
as a primary healthcare centre. This sample represented >25%
of all clinical isolates obtained from the region during the
study period. Twenty-five selected isolates were also tested by
MIRU-VNTR analysis.
Identification of mycobacteria
Mycobacterial isolates were grown on Lo¨wenstein–Jensen
medium and identified on the basis of colony morphology,
growth rate and pigmentation properties, niacin accumulation,
nitrate reduction and the p-nitro-a-benzoic acid test using the
Bactec MGIT 960 system (Becton Dickinson, Franklin Lakes,
NJ, USA). The susceptibilities of the isolates to primary anti-
tuberculosis drugs (streptomycin, isoniazid, rifampicin and
ethambutol) were determined using the Bactec MGIT 960
according to the manufacturer’s instructions. Chromosomal
DNA was extracted as described previously [10]. These
procedures were performed in the Department of Microbiol-
ogy at Zonguldak Karaelmas University Hospital.
Genotyping methods
Standard spoligotyping analysis was performed at the Pasteur
Institute of Guadeloupe, using home-made membranes [11].
The spoligotyping results, converted into octal format within
Excel spreadsheets, were analysed using Bionumerics v.4.5
(Applied Maths, Sint-Martins-Latem, Belgium) and Taxotron
(Taxolab, Institut Pasteur, Paris). The individual spoligotyping
patterns were compared with the patterns contained in an
updated SpolDB4 database (http://www.pasteur-guade
loupe.fr/tb/bd_myco.html). The updated in-house version
contained, at the time of this comparison, a total of 2808
spoligotyping international type (SIT) numbers, which are
patterns shared by two or more isolates among 63 473 clinical
isolates analysed from 121 countries. Major phylogenetic
clades were assigned according to signatures provided
in SpolDB4 [12], which tentatively defined 62 genetic
lineages ⁄ sub-lineages.
MIRU-VNTR analysis loci [13] were amplified from 12
genomic loci for selected isolates. PCR mixtures (final volume,
30 lL) consisted of 0.5 lM dNTPs, 2 mM MgCl2, di-
methylsulphoxide 10% v ⁄v, 1 · recombinant Taq buffer mix
(GE Healthcare, Little Chalfont, UK), 0.5 U of rTaq (GE
Healthcare), 0.3 lM each primer, and 1 lL of DNA extract.
Samples were amplified in a GeneAmp PCR system 9600
(Perkin Elmer-Applied Biosystems, Basel, Switzerland) using
an amplification profile of 10 min at 94C, followed by 35
cycles of 30 s at 94C, 60s at 60C and 2 min at 72C, with a
final extension for 10 min at 72C. DNA fragments were
separated by electrophoresis on agarose 1.5% w ⁄v gels, and
the number of copies of each MIRU-VNTR allele was calcu-
lated from the fragment sizes. The table used for MIRU-VNTR
allele scoring is available on request from the corresponding
author.
The dataset was compared to an updated version of the
SpoIBD4 database (designated SITVIT), which allows the
groupings according to spoligotypes and MIRU-VNTR alleles
to be compared [12].
Phylogenetic analysis
The pairwise distance between patterns was computed accord-
ing to the unweighted pair-group method using arithmetic
averages (UPGMA) method and the Jaccard index [14] using
PAUP (Phylogeny Analysis Using Parsimony) software [15].
This approach has proved to be useful for describing major
phylogeographical clades among MTC isolates [16,17].
RESULTS AND DISCUSSION
In total, 47 patterns were obtained according to
spoligotyping. These comprised 13 clusters con-
taining between two and 28 isolates, totalling 94
isolates, and 34 unique patterns (a clustering rate
of 73%). Of the 34 isolates with unique patterns,
six clinical isolates did not match with any isolates
within the database, whereas 28 patterns were
already present in the database. The full spoligo-
typing results for the Zonguldak dataset, together
with the UPGMA tree and main genotypes, are
shown in Fig. S1 (see Supplementary material).
Of the 113 isolates for which susceptibility test
results were available, 11 were multidrug-resis-
tant (MDR), while 23 were resistant to at least one
drug (not MDR) (Table 1). When the characteris-
tics of isolates were compared with the spoligo-
typing results, it was found that drug-resistant
isolates clustered at a higher level than suscepti-
ble isolates (p <0.02). In addition, the isolates
obtained from patients in the groups aged 17–39
and 40–63 years were clustered more closely than
those isolated from patients aged >63 years
(p 0.006).
Table 1. Main patient and isolate characteristics
Unique profile Clustered Total
Number of isolates 34 94 128
Patient age (if known)
0–16 years 0 1 1
17–39 years 10 44 54
40–63 years 7 29 36
>63 years 13 13 26
Drug susceptibility (if known)
Susceptible 26 53 79
Resistant to any drug 2 21 23
Multidrug-resistant 1 10 11
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The largest cluster was SIT53 (n = 28) (Fig. S1),
for which spoligotyping did not provide a precise
molecular identification (default clade). The sec-
ond largest cluster, SIT41 (n = 18), confirmed the
endemicity of the LAM7-TUR clade, shown
recently to belong to a new clade of genotypes
that was suggested to be phylogeographically
specific for Asia Minor, based on results obtained
in Malatya, Ankara and Samsun [6]. This clade
also appears to be endemic in Zonguldak. The
frequency of the SIT41 genotype (14%, or 20% if
variant types are included) agrees with previous
data from Istanbul (15%) [18]. The third largest
cluster was SIT50 (n = 10), which corresponds to
the classical Haarlem 3 isolates. There were two
clusters of six isolates (SIT42 and SIT47). SIT42
represents the LAM9 genotype clade, while SIT47
corresponds to the classical Haarlem 1 genotype
clade. The SIT4 genotype (n = 5) was shown
previously to be a direct offspring (by deletion)
of either the SIT33 (LAM3) or SIT34 (S) families
[19]. However, the demonstration of genetic
convergence for this SIT does not exclude the
possibility that SIT4 could stem from another
clade in this setting. SIT2125 (n = 5) has been
described as a specific variant of LAM7-TUR.
SIT284 (n = 4) was described in a previous study
[6], and may be endemic in Turkey. A preliminary
report indicated that this clonal complex also has
a high prevalence in Bulgaria (27th Annual
Conference of the European Society of Mycobac-
teriology, London, 2006; P76), and it is also
present in Iran [20]. Two clusters of three isolates
(SIT2077 and SIT52) and three clusters of two
isolates (SIT1122, SIT2162 and SIT608) were also
found. Three isolates of SIT2077 can be found in
the updated database, with two from Turkey and
one from the USA. SIT52 corresponds to the T2
clonal complex, which needs to be further char-
acterised. SIT1122 has been reported twice in the
west of Turkey, and is mainly found in isolates
from Europe. SIT2162 is represented in the data-
base by two clinical isolates from Turkey, and has
not been reported previously elsewhere. SIT608
has also been reported previously in Turkey. The
Beijing type was not detected in the present study.
The characteristics of the spoligotypes that
formed clusters in the present study are summar-
ised in Table 2.
When the dataset was compared with the
updated database, four new shared types were
created. SIT2120 was unique in the present data-
set (strain ZKU15) and matched with a clinical
isolate from Du¨zce, Turkey. SIT2125 was isolated
from five patients harbouring a variant of the
LAM7-TUR clade (additional absence of
spacer 38) and matched with a clinical isolate
from The Netherlands (a patient of unknown
origin). SIT2127 (isolate ZKU39, unique in the
dataset) was formed by matching ZKU39 with
pattern S01453 from the neighbouring Samsun
area of Turkey. SIT2128 (isolate ZKU46, unique in
the dataset) was formed by an unexplained match
with two clinical isolates from French Guyana.
The newly created shared types (n = 4) containing
eight isolates are shown in Table 3. An updated
public version of the database (SpolDB4) is
expected to be released during 2008.
Of the 34 patterns that were unique in this
dataset, six (Table 4) did not match with any
pattern in the database. Three of these isolates
were rare variants of the LAM7-TUR clade. The
presence of variants of the SIT41 signature sug-
gests an historical and ⁄ or epidemiological micro-
evolution of these genotypes in the Zonguldak
area.
Table 2. Characteristics of spoligotypes that were repre-
sented by clusters
Cluster No. of isolates % Characteristics
SIT53 28 21.8 T1, worldwide distribution
SIT41 18 14.06 LAM7-TUR, endemic in Turkey
SIT50 10 7.81 Haarlem 3, worldwide distribution
SIT42 6 4.6 LAM9
SIT47 6 4.6 Haarlem 1
SIT2125 5 3.9 Variant of LAM7-TUR
SIT4 5 3.9 LAM3 or S
SIT284 4 3.1 Also found in Bulgaria and Iran
SIT2077 3 2.34 Three more isolates in the database
from Turkey and the USA
SIT52 3 2.34 T2
SIT1122 2 1.56 Widespread in Europe
SIT2162 2 1.56 Two more isolates in the database
from Turkey
ST608 2 1.56 Two more isolates in the database
from Turkey
Total 94 73.4
SIT, spoligotyping international type.
Table 3. Newly created spoligotyping international types
(n = 4) representing matches between unique strains in
this study and strains in the updated spolDB4 database





2120 007777707760351 2 1 Du¨zce, Turkey
2125 777777404760571 6 5 The Netherlands
2127 777760007760751 2 1 Samsun, Turkey
2128 777707777760771 2 1 French Guyana
SIT, spoligotyping international type.
aSee [21].
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The phylogenetic significance of the LAM7-
TUR clade was investigated by complementary
MIRU-VNTR typing. In total, 17 SIT41 and eight
related spoligotypes were investigated using the
classic 12 allele format method [13]. The most
predominant MIRU-VNTR pattern was MIRU-
VNTR international type (MIT) 310 (digit code
215125113322), found in 19 (80%) isolates. Over-
all, MIRU-VNTR analysis confirmed the cluster-
ing results obtained by spoligotyping, as 15 of the
17 SIT41 isolates showed the same MIRU-VNTR
pattern, i.e., MIT310. Allelic variation was seen in
MIRU10 in four (16%) of 25 isolates, and in
MIRU31 in two (8%) of 25 isolates. These data
correlate well with data from a larger sample in
Istanbul, which revealed that MIT310 accounted
for 80–85% of isolates identified as SIT41 by
spoligotyping [18]. These results suggest that
these isolates either share a common ancestor or
are epidemiologically linked.
Finally, the available drug susceptibility results
indicated that there were 11 MDR isolates, four of
which belonged to the SIT41 (LAM7-TUR) profile,
and three of which belonged to SIT2125, a variant
of LAM7-TUR. The observed link between the
MDR status of a clone and SIT2125 could be an
important indicator of drug susceptibility based
on spoligotyping, although analysis of more cases
is required to confirm this observation.
In Turkey, national tuberculosis control is
implemented at three levels: at a central unit,
which is the national department responsible for
the preparation and application of the control
programme; at intermediate units, which coordi-
nate the smaller units in each province; and at
peripheral units, which are the tuberculosis dis-
pensaries that are responsible for diagnosis, treat-
ment and recording of the tuberculosis patients
and their contacts. There are one or more dispen-
saries in each province, but there have been
problems with patient recording and contact
tracing. As there has been no application of
directly observed therapy of short course, there
have been problems with patient adherence to
treatment. In addition, drug susceptibility testing
is not always performed for all patients when
treatment is initiated, which could potentially
result in treatment failure and transmission of
drug-resistant tuberculosis (some isolates in this
study were tested retrospectively for drug resis-
tance). Efforts have been made to improve the
recording system and the availability of drug
susceptibility testing, and directly observed ther-
apy of short course has been used for patients in
Zonguldak since 2006, which should help to
decrease the transmission of the disease.
In conclusion, the present study demonstrated
that the most common spoligotyping profile
found in the Zonguldak region is SIT53 (T1),
followed by SIT41 (LAM7-TUR) and SIT50 (Haar-
lem 3). SIT284 seems to be another phylogeo-
graphically specific genotype that may be
endemic in Turkey. The LAM7-TUR clade,
although highly prevalent in Zonguldak, remains
well-conserved phylogenetically, with only a few
single-allele variants, which suggests that it has
expanded relatively recently. Further studies are
needed to understand the molecular epidemiol-
ogy of tuberculosis in Turkey and the phyloge-
netic significance of the LAM7-TUR clade within
this country. In addition, a tuberculosis control
programme is clearly needed, as the spoligotyp-
ing clustering rates are high in this region.
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Table 4. Isolates from the present
study (n = 6) with unmatched spo-
ligotype patterns
Isolate no. Octal no.a Clade MIT Drug sensitivity
TUR0720050ZKU132 777736777760571 X 383 Non-MDR
TUR0720031ZKU26 777757404760771 LAM7-TUR 930 Non-MDR
TUR0720031ZKU38 177777774020731 Haarlem Orphan Non-MDR
TUR0720041ZKU100 776777404760771 LAM7-TUR 310 Non-MDR
TUR0720051ZKU108 577777404760771 LAM7-TUR 194 Non-MDR
TUR0720050ZKU120 037636377760771 ST284 variant 380 Non-MDR
MIT, MIRU-VNTR international type; MIRU-VNTR, mycobacterial interspersed repetitive unit–variable number
tandem repeat analysis; MDR, multidrug-resistant.
aSee [21].
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SUPPLEMENTARY MATERIAL
The following supplementary material is avail-
able for this article online at http://www.black
well.synergy.com:
Fig. S1. UPGMA tree constructed by numerical
analysis of spoligotyping data using Taxotron
software.
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